Haro Girón, S.; Monserrat Sanz, J.; Ortega, M.A.; Garcia-Montero, C.; Fraile-Martínez, O.; Gómez-Lahoz, A.M.; Boaru, D.L.; de Leon-Oliva, D.; Guijarro, L.G.; Atienza-Perez, M.;
et al. Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury. J. Pers. Med. 2023, 13, 626.
https://doi.org/10.3390/jpm13040626
AMA Style
Haro Girón S, Monserrat Sanz J, Ortega MA, Garcia-Montero C, Fraile-Martínez O, Gómez-Lahoz AM, Boaru DL, de Leon-Oliva D, Guijarro LG, Atienza-Perez M,
et al. Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury. Journal of Personalized Medicine. 2023; 13(4):626.
https://doi.org/10.3390/jpm13040626
Chicago/Turabian Style
Haro Girón, Sergio, Jorge Monserrat Sanz, Miguel A. Ortega, Cielo Garcia-Montero, Oscar Fraile-Martínez, Ana M. Gómez-Lahoz, Diego Liviu Boaru, Diego de Leon-Oliva, Luis G. Guijarro, Mar Atienza-Perez,
and et al. 2023. "Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury" Journal of Personalized Medicine 13, no. 4: 626.
https://doi.org/10.3390/jpm13040626
APA Style
Haro Girón, S., Monserrat Sanz, J., Ortega, M. A., Garcia-Montero, C., Fraile-Martínez, O., Gómez-Lahoz, A. M., Boaru, D. L., de Leon-Oliva, D., Guijarro, L. G., Atienza-Perez, M., Diaz, D., Lopez-Dolado, E., & Álvarez-Mon, M.
(2023). Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury. Journal of Personalized Medicine, 13(4), 626.
https://doi.org/10.3390/jpm13040626
